Technical Analysis for AIMT - Aimmune Therapeutics, Inc.
|Grade||Last Price||% Change||Price Change|
AIMT closed down 3.66 percent on Thursday, January 17, 2019, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
|Weak or Absent||Down||Down||Down|
|See historical AIMT trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 17||MACD Bearish Centerline Cross||Bearish||0.15%|
|Jan 17||MACD Bearish Signal Line Cross||Bearish||0.15%|
|Jan 17||Stochastic Reached Oversold||Weakness||0.15%|
|Jan 17||Down 3 Days in a Row||Weakness||0.15%|
|Jan 17||Down 4 Days in a Row||Weakness||0.15%|
|Jan 17||Down 5 Days in a Row||Weakness||0.15%|
|Jan 17||Oversold Stochastic||Weakness||0.15%|
|Jan 16||20 DMA Resistance||Bearish||-3.52%|
|Jan 16||Inside Day||Range Contraction||-3.52%|
|Jan 16||Down 3 Days in a Row||Weakness||-3.52%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. Its characterized oral desensitization immunotherapy includes AR101, a product for the treatment of peanut allergy in children and adults that has completed a Phase II study. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. in May 2015. The company was founded in 2011 and is headquartered in Brisbane, California.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more AIMT news...
|52 Week High||42.0|
|52 Week Low||21.38|
|200-Day Moving Average||28.0401|
|50-Day Moving Average||25.0926|
|20-Day Moving Average||24.126|
|10-Day Moving Average||24.763|
|Average True Range||1.5829|
|Chandelier Exit (Long, 3 ATRs )||21.9313|
|Chandelier Exit (Short, 3 ATRs )||26.1287|
|Upper Bollinger Band||26.5956|
|Lower Bollinger Band||21.6564|
|Percent B (%b)||0.19|
|MACD Signal Line||-0.0157|
|Market Cap||1.14 Billion|
|Num Shares||50.5 Million|
|Price-to-Earnings (P/E) Ratio||-10.05|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||24.64|
|Resistance 3 (R3)||24.86||24.40||24.30|
|Resistance 2 (R2)||24.40||23.89||24.29||24.18|
|Resistance 1 (R1)||23.51||23.57||23.28||23.29||24.07|
|Support 1 (S1)||22.16||22.54||21.93||21.94||21.15|
|Support 2 (S2)||21.70||22.22||21.59||21.04|
|Support 3 (S3)||20.81||21.70||20.92|
|Support 4 (S4)||20.59|